{"id":"https://openalex.org/W2937536573","doi":"https://doi.org/10.1097/cad.0000000000000791","title":"Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models","display_name":"Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models","publication_year":2019,"publication_date":"2019-04-18","ids":{"openalex":"https://openalex.org/W2937536573","doi":"https://doi.org/10.1097/cad.0000000000000791","mag":"2937536573","pmid":"https://pubmed.ncbi.nlm.nih.gov/30998512","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6749973"},"language":"en","primary_location":{"id":"doi:10.1097/cad.0000000000000791","doi":"https://doi.org/10.1097/cad.0000000000000791","is_oa":true,"landing_page_url":"https://doi.org/10.1097/cad.0000000000000791","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/cad.0000000000000791","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101548144","display_name":"You Lang Zhou","orcid":"https://orcid.org/0000-0003-0465-5509","observed_orcids":["https://orcid.org/0000-0003-0465-5509"]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"You Zhou","raw_affiliation_strings":["Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","institution_ids":["https://openalex.org/I4387155163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060141911","display_name":"Chao Fu","orcid":"https://orcid.org/0000-0003-3716-5725","observed_orcids":["https://orcid.org/0000-0003-3716-5725"]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chao Fu","raw_affiliation_strings":["Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","institution_ids":["https://openalex.org/I4387155163"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yidi Kong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yidi Kong","raw_affiliation_strings":["Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","institution_ids":["https://openalex.org/I4387155163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079606398","display_name":"Desi Pan","orcid":"https://orcid.org/0000-0002-2104-3902","observed_orcids":["https://orcid.org/0000-0002-2104-3902"]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Desi Pan","raw_affiliation_strings":["Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","institution_ids":["https://openalex.org/I4387155163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112631321","display_name":"Yanan Wang","orcid":"https://orcid.org/0000-0002-7433-3567","observed_orcids":["https://orcid.org/0000-0002-7433-3567"]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yanan Wang","raw_affiliation_strings":["Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","institution_ids":["https://openalex.org/I4387155163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102378485","display_name":"Shengjian Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shengjian Huang","raw_affiliation_strings":["Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","institution_ids":["https://openalex.org/I4387155163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100351565","display_name":"Zhibin Li","orcid":"https://orcid.org/0000-0003-4752-5528","observed_orcids":["https://orcid.org/0000-0003-4752-5528","https://orcid.org/0000-0001-5849-6334"]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Zhibin Li","raw_affiliation_strings":["Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","institution_ids":["https://openalex.org/I4387155163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109525574","display_name":"Zhiqiang Ning","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhiqiang Ning","raw_affiliation_strings":["Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","institution_ids":["https://openalex.org/I4387155163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085142395","display_name":"Xianping Lu","orcid":"https://orcid.org/0000-0003-3933-0931","observed_orcids":["https://orcid.org/0000-0003-3933-0931"]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xianping Lu","raw_affiliation_strings":["Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","institution_ids":["https://openalex.org/I4387155163"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Song Shan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Song Shan","raw_affiliation_strings":["Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","institution_ids":["https://openalex.org/I4387155163"]}]},{"author_position":"last","author":{"id":null,"display_name":"Lijun Xin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155163","display_name":"Shenzhen Chipscreen Biosciences Co.","ror":"https://ror.org/04b1hsx72","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Lijun Xin","raw_affiliation_strings":["Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","to Lijun Xin, PhD, Shenzhen Chipscreen Biosciences Co. Ltd., BIO-Incubator, Suit 2-603B, Shenzhen Hi-Tech Industrial Park, Shenzhen, Guangdong 518057, China Tel: + 86 755 2695 2126; fax: + 86 755 2695 7291; e-mail: [email\u00a0protected]","e-mail: [email\u00a0protected]","fax: + 86 755 2695 7291","to Lijun Xin, PhD, Shenzhen Chipscreen Biosciences Co. Ltd., BIO-Incubator, Suit 2-603B, Shenzhen Hi-Tech Industrial Park, Shenzhen, Guangdong 518057, China Tel: + 86 755 2695 2126"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Chipscreen Biosciences Co. Ltd., Shenzhen, Guangdong, China","institution_ids":["https://openalex.org/I4387155163"]},{"raw_affiliation_string":"to Lijun Xin, PhD, Shenzhen Chipscreen Biosciences Co. Ltd., BIO-Incubator, Suit 2-603B, Shenzhen Hi-Tech Industrial Park, Shenzhen, Guangdong 518057, China Tel: + 86 755 2695 2126; fax: + 86 755 2695 7291; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I4387155163"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: + 86 755 2695 7291","institution_ids":[]},{"raw_affiliation_string":"to Lijun Xin, PhD, Shenzhen Chipscreen Biosciences Co. Ltd., BIO-Incubator, Suit 2-603B, Shenzhen Hi-Tech Industrial Park, Shenzhen, Guangdong 518057, China Tel: + 86 755 2695 2126","institution_ids":["https://openalex.org/I4387155163"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5100351565"],"corresponding_institution_ids":["https://openalex.org/I4387155163"],"apc_list":null,"apc_paid":null,"fwci":0.8986,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.74334483,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"30","issue":"9","first_page":"909","last_page":"916"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7348999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7348999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.20229999721050262,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.03519999980926514,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8930000066757202},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.8029999732971191},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8059999942779541},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":1.0},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":1.0},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8309999704360962},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":1.0},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.9919999837875366},{"id":"https://openalex.org/keywords/ascites","display_name":"ascites","score":0.6079999804496765},{"id":"https://openalex.org/keywords/h22-hepatocellular-carcinoma","display_name":"H22 hepatocellular carcinoma","score":0.7770000100135803},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7434673309326172},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6461706757545471},{"id":"https://openalex.org/C2780931953","wikidata":"https://www.wikidata.org/wiki/Q9371","display_name":"Spleen","level":2,"score":0.5906848907470703},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.5887672305107117},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5680556893348694},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.543100893497467},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.5072305202484131},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.4868304133415222},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.47795772552490234},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4367515444755554},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4337994456291199},{"id":"https://openalex.org/C55721878","wikidata":"https://www.wikidata.org/wiki/Q15220362","display_name":"Myeloid-derived Suppressor Cell","level":4,"score":0.42059239745140076},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4147946834564209},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34584841132164},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32456541061401367},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.22225356101989746},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.1670011281967163},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.055039286613464355},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001201","descriptor_name":"Ascites","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/cad.0000000000000791","doi":"https://doi.org/10.1097/cad.0000000000000791","is_oa":true,"landing_page_url":"https://doi.org/10.1097/cad.0000000000000791","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6749973","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6749973","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer Drugs","raw_type":"Text"},{"id":"pmid:30998512","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30998512","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1097/cad.0000000000000791","doi":"https://doi.org/10.1097/cad.0000000000000791","is_oa":true,"landing_page_url":"https://doi.org/10.1097/cad.0000000000000791","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320329174","display_name":"Shenzhen Municipal Science and Technology Innovation Council","ror":"https://ror.org/017n8df75"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1964871165","https://openalex.org/W1965696083","https://openalex.org/W1971837077","https://openalex.org/W1976617226","https://openalex.org/W1980241157","https://openalex.org/W1980485314","https://openalex.org/W1993519783","https://openalex.org/W1995483670","https://openalex.org/W1997729483","https://openalex.org/W2044267375","https://openalex.org/W2058818406","https://openalex.org/W2060672294","https://openalex.org/W2061743943","https://openalex.org/W2062783581","https://openalex.org/W2063744431","https://openalex.org/W2078830973","https://openalex.org/W2080202443","https://openalex.org/W2107083699","https://openalex.org/W2107277218","https://openalex.org/W2107398170","https://openalex.org/W2109157584","https://openalex.org/W2113544323","https://openalex.org/W2114360920","https://openalex.org/W2129411754","https://openalex.org/W2155127143","https://openalex.org/W2285436607","https://openalex.org/W2473347405","https://openalex.org/W2560499218","https://openalex.org/W2564973499","https://openalex.org/W2606367731","https://openalex.org/W2755067822","https://openalex.org/W2783703728","https://openalex.org/W2791328450","https://openalex.org/W2801571624","https://openalex.org/W4324262440"],"related_works":["https://openalex.org/W2889895672","https://openalex.org/W3111051850","https://openalex.org/W2898267386","https://openalex.org/W4292429818","https://openalex.org/W3028820493","https://openalex.org/W2793316067","https://openalex.org/W2904434745","https://openalex.org/W2894003555","https://openalex.org/W3135040913","https://openalex.org/W2494328932"],"abstract_inverted_index":{"As":[0],"a":[1],"novel":[2],"orally":[3],"active":[4],"multitarget":[5],"small":[6],"molecule":[7],"inhibitor,":[8],"CS2164":[9,28,99,112,160,180,204],"has":[10,44],"shown":[11],"broad":[12],"antitumor":[13,31,88,96,183],"activities":[14,189],"against":[15],"several":[16,170],"human":[17],"tumor":[18,37,55,125,157],"xenograft":[19],"models":[20,69,108],"in":[21,33,70,102,109,120,124,135,153,173,190,205],"immune-compromised":[22],"mice.":[23],"However,":[24],"the":[25,54,59,62,87,95,121,136,154,162,200],"ability":[26],"of":[27,77,92,98,129,140,169,203],"to":[29,47,85],"modulate":[30],"immunity":[32],"an":[34,78,182],"immune-competent":[35],"mouse":[36,191],"model":[38],"remains":[39],"undefined,":[40],"although":[41],"antiangiogenic":[42],"treatment":[43,113],"been":[45],"reported":[46],"affect":[48],"immune":[49,56,116],"cell":[50,81,117],"infiltration":[51],"and":[52,64,89,105,123,131,150,156,166,194],"remodel":[53],"microenvironment.":[57],"In":[58],"present":[60],"study,":[61],"subcutaneous":[63,104],"ascites":[65,106],"hepatocellular":[66],"carcinoma":[67],"(HCC)":[68],"syngeneic":[71,110],"Balb/c":[72],"mice":[73],"established":[74],"by":[75],"inoculation":[76],"H22":[79],"hepatoma":[80],"line":[82],"were":[83,100],"utilized":[84],"investigate":[86],"immunomodulatory":[90,188],"effects":[91,97],"CS2164.":[93],"Although":[94],"validated":[101],"both":[103,119],"HCC":[107,192],"mice,":[111],"consistently":[114],"modulated":[115],"populations,":[118],"periphery":[122],"microenvironments,":[126],"with":[127,186],"upregulation":[128],"CD4":[130],"CD8":[132],"T":[133,145],"cells":[134],"spleen,":[137],"but":[138],"downregulation":[139],"immunosuppressive":[141],"populations":[142],"including":[143],"regulatory":[144],"cells,":[146,149],"myeloid-derived":[147],"suppressor":[148],"tumor-associated":[151],"macrophages":[152],"spleen":[155],"tissues.":[158],"Furthermore,":[159],"increased":[161],"relative":[163],"gene":[164],"expression":[165],"protein":[167],"production":[168],"proinflammatory":[171],"cytokines":[172],"tumor-related":[174],"ascites.":[175],"These":[176],"results":[177],"indicate":[178],"that":[179],"exerts":[181],"effect":[184],"associated":[185],"its":[187],"models,":[193],"may":[195],"also":[196],"provide":[197],"evidence":[198],"for":[199],"immunotherapy":[201],"potentiation":[202],"future":[206],"cancer":[207],"treatment.":[208]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-04-25T00:00:00"}